PerkinElmer's Q2 Revenues Rise 4 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its second-quarter revenues increased 4 percent year over year, beating Wall Street estimates on the top and bottom line.

The Waltham, Mass.-based firm brought in total revenues of $543.3 million for the three months ended June 30, compared to $521.8 million for the second quarter of 2012. Analysts, on average, had expected revenues of $533 million.

Its organic revenue growth for the quarter was 3 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.